Incorporating Novel Muscarinic Agents for Schizophrenia Into Clinical Practice: Overcoming Clinical Inertia
May 28, 2026 Miami Beach, Florida
The Safety of Sodium Oxybate in Treating Narcolepsy
Clete A. Kushida, MD, PhD
Sally Ibrahim, MD, FAAP
Key Differences Among the Clinical Manifestations of Narcolepsy Symptoms in Children Versus Adults
Funke Afolabi-Brown, MD
Pediatric Narcolepsy: Psychological and Social Comorbidities
Kiran Maski, MD, MPH
Early Diagnosis: Its Pivotal Role in Optimizing Outcomes in Pediatric Patients with Narcolepsy
Pediatric Narcolepsy: Physical Comorbidities
Pediatric Narcolepsy: A Primer for Clinicians Who Manage Children
Pediatric Narcolepsy: How to Address Its Burden of Illness Through Prompt Recognition, Diagnosis, and Management
Anne M. Morse, DO
Narcolepsy’s Burden of Illness: Its Impact on the Child and Family
Evolving Therapy for Managing Pediatric Narcolepsy: Once-Nightly Sodium Oxybate
Evolving Therapy for Managing Pediatric Narcolepsy: Wake-Promoting Pitolisant
Loading...
We're glad to see you're enjoying Prova Education… but how about a more personalized experience?
Press cancel to remain on Prova Education. Press the link below or the continue button to keep going.